Friday, 21 March 2025
  
Login

Australia's most trusted
source of pharma news

Friday, 21 March 2025
News

New drugs to watch... and why

Posted 18 March 2025 AM

A new generation of treatments coming to fruition could rake in combined sales of US$ 30.5 billion in the G7 countries alone in 2030 with four products already either approved for use in Australia or under TGA review.

Clarivate has released a list of 11 Drugs to Watch in 2025 as they begin their blockbuster run and/or transform treatment paradigms over the next five years. These candidates have either been recently launched in the US or are expected to hit the market this year.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (31)

Clinical & Medical, R&D (12)

Regulatory, Pharmacovigilance & QA (1)

Other (18)

Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.